The Efficacy and Safety of Daptomycin in the Treatment of Gram-positive Bacterial Infection.
Clinical trial NCT04546815 · UNKNOWN
Trial details
- NCT number
- NCT04546815
- Sponsor
- Jiangsu Hengrui Pharmaceutical Co., Ltd.
- Status
- UNKNOWN
- Study type
- OBSERVATIONAL
- Start date
- 2020-08-25
- Primary completion
- 2022-08-01
- Enrollment
- 2000
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.